ECOR: CG Equity Research
electroCore, Inc.
(NASDAQ: ECOR)
Market Cap: $51M
Cash: $11.6M
2026E Revenue: $44M
EV/2026E Revenue: ~1.0x
Cash: $11.6M
2026E Revenue: $44M
EV/2026E Revenue: ~1.0x
OUTPERFORM
CG Rating
$22.00
Price Target
~+108%
Upside
Key Investment Highlights
1
Accelerating Revenue Growth
20%+ year-over-year growth driven by VA, prescription, and fast-scaling consumer channels.
2
High-Margins, Scalable Model
An 85–87% gross margin business positioned to scale toward EBITDA breakeven as revenue expands.
3
Expanding
Platform
Platform
FDA-cleared migraine and fibromyalgia therapies with growing wellness and military applications.
Latest Research Reports
ECOR: Price Performance
Contact Us
For detailed financial projections, clinical data, regulatory pathway, and commercialization strategy, contact ecor@cg.capital to access additional investor materials.